Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1203-1211

  Hao, Meili ^a   Chen, Xiangmei ^b   Zhang, Ting ^b   Shen, Tao ^b   Xie, Qing ^b   Xing, Xiujuan ^b   Gu, Hongxi ^a   Lu, Fengmin ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cancer; Cell proliferation; Cyclin D1; Cyclin dependent kinase 4; Nuclear export

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; MUTANT PROTEIN; NOTCH1 RECEPTOR; RETINOBLASTOMA PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; UPREGULATION;

EID: 80052723510     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.404     Document Type: Article

References (41)

1. Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342, 1993.
2. Lundberg AS and Weinberg RA: Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18: 753-761, 1998.
3. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
4. Coqueret O: Linking cyclins to transcriptional control. Gene 299: 35-55, 2002.
5. Bienvenu F, Jirawatnotai S, Elias JE, et al: Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 463: 374-378, 2010.
6. Fu M, Rao M, Bouras T, et al: Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 280: 16934-16941, 2005.
7. Gladden AB and Diehl JA: Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem 96: 906-913, 2005.
8. Deshpande A, Sicinski P and Hinds PW: Cyclins and cdks in development and cancer: a perspective. Oncogene 24: 2909-2915, 2005.
9. Gillett C, Smith P, Gregory W, et al: Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69: 92-99, 1996.
10. Sicinski P, Donaher JL, Parker SB, et al: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630, 1995.
11. Bartkova J, Lukas J, Strauss M and Bartek J: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 58: 568-573, 1994.
12. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J: Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55: 949-956, 1995.
13. Hibberts NA, Simpson DJ, Bicknell JE, et al: Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res 5: 2133-2139, 1999.
14. Hemmer S, Wasenius VM, Haglund C, et al: Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol 158: 1355-1362, 2001.
15. Ikeguchi M, Sakatani T, Ueta T and Kaibara N: Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 127: 531-536, 2001.
16. Jin M, Inoue S, Umemura T, et al: Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer 34: 207-218, 2001.
17. Alt JR, Cleveland JL, Hannink M and Diehl JA: Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 14: 3102-3114, 2000.
18. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW and Adams JM: Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13: 2124-2130, 1994.
19. Lovec H, Grzeschiczek A, Kowalski MB and Moroy T: Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13: 3487-3495, 1994.
20. Gladden AB, Woolery R, Aggarwal P, Wasik MA and Diehl JA: Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 25: 998-1007, 2006.
21. Diehl JA, Zindy F and Sherr CJ: Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 11: 957-972, 1997.
22. Germain D, Russell A, Thompson A and Hendley J: Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286. J Biol Chem 275: 12074-12079, 2000.
23. Diehl JA, Cheng M, Roussel MF and Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511, 1998.
24. Lu F, Gladden AB and Diehl JA: An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 63: 7056-7061, 2003.
25. Benzeno S, Lu F, Guo M, et al: Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 25: 6291-6303, 2006.
26. Moreno-Bueno G, Rodriguez-Perales S, Sanchez-Estevez C, et al: Cyclin D1 gene (CCND1) mutations in endometrial cancer. Oncogene 22: 6115-6118, 2003.
27. Cobrinik D: Pocket proteins and cell cycle control. Oncogene 24: 2796-2809, 2005.
28. Shinozaki H, Ozawa S, Ando N, et al: Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 2: 1155-1161, 1996.
29. Shamma A, Doki Y, Shiozaki H, et al: Cyclin D1 overexpression in esophageal dysplasia: A possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 16: 261-266, 2000.
30. Leveque C, Marsaud V, Renoir JM and Sola B: Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes. Exp Cell Res 313: 2719-2729, 2007.
31. Guo Y, Yang K, Harwalkar J, et al: Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 24: 2599-2612, 2005.
32. Yang K, Guo Y, Stacey WC, et al: Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. BMC Cell Biol 7: 33, 2006.
33. Alao JP, Stavropoulou AV, Lam EW, Coombes RC and Vigushin DM: Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Mol Cancer 5: 8, 2006.
34. Feng Q, Sekula D, Muller R, Freemantle SJ and Dmitrovsky E: Uncovering residues that regulate cyclin D1 proteasomal degradation. Oncogene 26: 5098-5106, 2007.
35. Agami R and Bernards R: Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102: 55-66, 2000.
36. Alao JP: The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 6: 24, 2007.
37. Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU and Diehl JA: Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 27: 1231-1242, 2008.
38. Truong LN and Wu X: Prevention of DNA re-replication in eukaryotic cells. J Mol Cell Biol 3: 13-22, 2011.
39. Aggarwal P, Lessie MD, Lin DI, et al: Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev 21: 2908-2922, 2007.
40. Spruck CH, Won KA and Reed SI: Deregulated cyclin E induces chromosome instability. Nature 401: 297-300, 1999.
41. Tort F, Bartkova J, Sehested M, Orntoft T, Lukas J and Bartek J: Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis. Cancer Res 66: 10258-10263, 2006.